Foresite Capital Management III as of June 30, 2019
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 18 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 18.9 | $58M | 2.0M | 29.55 | |
| Blueprint Medicines (BPMC) | 14.5 | $44M | 468k | 94.33 | |
| Alder Biopharmaceuticals | 11.4 | $35M | 2.9M | 11.77 | |
| Immunomedics | 8.8 | $27M | 1.9M | 13.87 | |
| Ascendis Pharma A S (ASND) | 7.7 | $24M | 204k | 115.15 | |
| Myokardia | 5.2 | $16M | 314k | 50.14 | |
| Aimmune Therapeutics | 4.4 | $14M | 647k | 20.82 | |
| Epizyme | 4.1 | $13M | 998k | 12.55 | |
| Audentes Therapeutics | 3.9 | $12M | 315k | 37.86 | |
| Replimune Group (REPL) | 3.8 | $11M | 780k | 14.66 | |
| Cymabay Therapeutics | 3.7 | $11M | 1.6M | 7.16 | |
| Arcus Biosciences Incorporated (RCUS) | 3.6 | $11M | 1.4M | 7.95 | |
| Acceleron Pharma | 3.4 | $11M | 255k | 41.08 | |
| Natera (NTRA) | 2.6 | $7.9M | 287k | 27.58 | |
| Tocagen | 1.2 | $3.8M | 568k | 6.68 | |
| Wave Life Sciences (WVE) | 1.2 | $3.6M | 140k | 26.09 | |
| Biohaven Pharmaceutical Holding | 0.9 | $2.9M | 65k | 43.79 | |
| BioDelivery Sciences International | 0.7 | $2.1M | 455k | 4.65 |
